Novo Nordisk - ADR

NYSE:NVO   10:29:33 AM EDT
+1.54 (+1.09%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)475.17B
Current PE5.32
Forward PE 41.62
2yr Forward PE 34.05
See more stats
Estimates Current Quarter
Revenue$9.76 Billion
Adjusted EPS$0.80
See more estimates
10-Day MA$141.18
50-Day MA$132.09
200-Day MA$113.49
See more pivots

Novo Nordisk - ADR Stock, NYSE:NVO

Novo All�©, Novo All�© 1, Bagsv��rd, Capital Region 2880
Phone: +
Number of Employees: 63370


Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in BagsvÃ?Â?rd, Denmark.